Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract

    2026-04-12

    Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Technical Workflow Guidance

    What This Product Solves

    The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) addresses a fundamental challenge in protein biochemistry: preserving protein integrity during extraction and preparative workflows by minimizing proteolytic degradation from endogenous enzymes. Its EDTA-free composition is specifically formulated for workflows that require preservation of divalent cations, such as phosphorylation analysis, kinase assays, and metalloprotein studies. The inclusion of inhibitors targeting serine, cysteine, aspartic proteases, and aminopeptidases ensures broad-spectrum protection across common cell and tissue lysate types. This cocktail is suitable for sensitive downstream analyses including Western blotting, co-immunoprecipitation (Co-IP), and pull-down assays, and is particularly advantageous where EDTA-mediated interference with metal-dependent proteins or processes must be avoided.

    This product is not appropriate for workflows requiring chelation of divalent cations as a primary means of protease inhibition, nor does it replace specialized inhibitors for highly atypical protease classes beyond those specified in the composition.

    Protocol Parameters

    • assay: General protein extraction | value_with_unit: 1:100 (v/v) dilution | applicability: Standard for lysate preparation from mammalian, yeast, or bacterial cells | rationale: Ensures optimal inhibitor concentration for broad-spectrum protease inhibition during lysis | source_type: product_spec [product_url]
    • assay: Western blot sample prep | value_with_unit: 1:100 (v/v) dilution | applicability: Protease protection during denaturing and non-denaturing sample preparation | rationale: Preserves protein targets for immunodetection without chelating metal cofactors, critical for phosphorylation-sensitive workflows | source_type: workflow_recommendation [internal_article_url]
    • assay: Co-immunoprecipitation (Co-IP) and kinase assays | value_with_unit: 1:100 (v/v) dilution | applicability: Maintenance of native protein interactions and enzymatic activity in immunoprecipitation or kinase analysis | rationale: EDTA-free formulation preserves essential divalent cations, supporting accurate detection of phosphorylation events and protein complexes | source_type: workflow_recommendation [internal_article_url]
    • assay: Storage stability | value_with_unit: Stable ≥12 months at -20°C | applicability: Stock solution maintenance for routine laboratory use | rationale: Ensures consistent inhibitor potency and performance over time when stored as instructed | source_type: product_spec [product_url]

    Workflow Setup and QC Checklist

    • Thaw the 100X stock on ice immediately before use; avoid repeated freeze-thaw cycles to maintain inhibitor activity (product_spec).
    • Add the Protease Inhibitor Cocktail directly to lysis buffer immediately prior to cell or tissue disruption. For a 1 mL lysate, add 10 μL of inhibitor cocktail to achieve 1:100 dilution (workflow_recommendation).
    • Ensure thorough mixing to distribute inhibitors evenly throughout the sample.
    • Confirm that the lysis buffer does not already contain EDTA or other chelators if preservation of divalent cations is required for downstream assays (workflow_recommendation).
    • For phosphorylation analysis or kinase assays, verify that the absence of EDTA is compatible with your detection method and that buffer components do not interfere with enzymatic activity.
    • Document all additions, including lot numbers and dilution factors, to facilitate troubleshooting and reproducibility.

    Common Failure Modes and Fixes

    • Residual proteolysis detected in lysates: Confirm inhibitor was added at the recommended 1:100 dilution and mixed promptly. Check that no freeze-thaw degradation of the inhibitor stock has occurred. If persistent, confirm that protease classes present in your sample are covered by the inhibitor spectrum (product_spec, workflow_recommendation).
    • Phosphorylation signal loss in kinase assays: Ensure no inadvertent EDTA contamination from other buffer components. Verify inhibitor cocktail addition prior to lysis, as delayed addition cannot reverse prior proteolysis (workflow_recommendation).
    • Precipitation or sample turbidity after addition: Gradually equilibrate samples to 4°C and add inhibitor cocktail slowly with gentle mixing. Ensure DMSO compatibility with your lysis buffer. If precipitation persists, check for incompatibility between buffer salts and DMSO (workflow_recommendation).
    • Inconsistent Western blot signals: Standardize sample processing timelines, maintain all samples on ice, and add inhibitor cocktail prior to any mechanical disruption (workflow_recommendation).

    Scope and Limitations

    • This Protease Inhibitor Cocktail is optimized for workflows where preservation of divalent cations is required, such as phosphorylation analysis, kinase activity assays, and studies involving metal-dependent proteins (product_spec).
    • It is not intended for applications where chelation-mediated protease inhibition (e.g., EDTA-based) is required, nor does it cover all possible protease classes beyond those specified in the ingredient list (product_spec).
    • Users should validate compatibility with their specific cell or tissue type, as highly atypical protease profiles may require supplementation with specialized inhibitors (workflow_recommendation).
    • The DMSO-based formulation is generally compatible with standard lysis buffers, but may not be suitable for all buffer compositions; pilot testing is advised for novel protocols (workflow_recommendation).

    For further discussion of methodological imperatives and troubleshooting in phosphorylation-sensitive workflows, see: Revolutionizing Protein Complex Integrity: Strategic Guidance for EDTA-Free Protease Inhibitors (relates to advanced workflow setup and benchmarking); and Protease Inhibitor Cocktail EDTA-Free: Precision in Protein Research (addresses artifact prevention and data reproducibility).

    Conclusion

    The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO provides a practical and reliable means of protecting proteins from enzymatic degradation during extraction and preparation, with particular strength in workflows sensitive to divalent cations and phosphorylation status. Its broad-spectrum inhibitor profile, EDTA-free formulation, and DMSO solvent compatibility make it a versatile tool for molecular biology researchers focused on high-fidelity sample preservation for downstream analyses such as Western blotting, Co-IP, and kinase assays. Consistent application of the outlined best practices will help ensure sample integrity and reproducibility in protease-sensitive workflows.